2008
DOI: 10.3797/scipharm.0808-12
|View full text |Cite
|
Sign up to set email alerts
|

A New High-Throughput LC-MS/MS Assay for Therapeutic Level Monitoring of Valproic Acid in Human Plasma

Abstract: A new high-throughput liquid chromatographic tandem mass spectrometric (LC-MS/MS) assay for the quantification of valproic acid in human plasma was developed and validated. The separation was performed on a Zorbax SB-C18 column under isocratic conditions using a 48:52 (v/v) mixture of acetonitrile and 0.1% (v/v) acetic acid in water at 45 °C with a flow rate of 0.8 mL/min. The detection of valproic acid was performed in SIM mode (m/z 143.1). The human plasma samples (0.2 mL) were deproteinized with methanol an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 14 publications
0
5
0
Order By: Relevance
“…One previously described HPLC method, based on the extraction of VPA with hexane from acidified plasma, evaporation and derivatization with 2-bromo-2´-acetonaphtone, offered the LLOQ of 0.05 µg/mL using 160 µL of plasma [ 14 ]. When LC-MS/MS methods were applied, the LLOQ of 0.2–5 µg/mL using 200 µL of plasma were reported [ 20 , 21 , 23 ]. In one of these methods, MS/MS detection required the extraction of VPA from acidified plasma with methylene chloride, then two step derivatization with 2-chloro-1-methylpyridinium iodide and 4-dimethylaminobenzylamine dihydrochloride, shaking for 1 h and using evaporation [ 23 ].…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…One previously described HPLC method, based on the extraction of VPA with hexane from acidified plasma, evaporation and derivatization with 2-bromo-2´-acetonaphtone, offered the LLOQ of 0.05 µg/mL using 160 µL of plasma [ 14 ]. When LC-MS/MS methods were applied, the LLOQ of 0.2–5 µg/mL using 200 µL of plasma were reported [ 20 , 21 , 23 ]. In one of these methods, MS/MS detection required the extraction of VPA from acidified plasma with methylene chloride, then two step derivatization with 2-chloro-1-methylpyridinium iodide and 4-dimethylaminobenzylamine dihydrochloride, shaking for 1 h and using evaporation [ 23 ].…”
Section: Resultsmentioning
confidence: 99%
“…In turn, the centrifugal ultrafiltration followed by a direct GC method offered the linearity range from 0.56 µg/mL [ 24 ]. Because the mean concentration of VPA in plasma of patients with epilepsy is usually between 40 and 120 μg/mL [ 14 , 20 , 21 ], these LLOQ are optimal for the determination of VPA in patients with epilepsy after typical dosing. However, effective VPA dosing in different types of cancer is yet to be discovered.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Other methodology is available employing varying versions of LC -MS technology (Beyer et al 2007;Vlase et al 2009). In addition, a fl uorescence polarization immunoassay ( FPIA) method has been adapted to allow the determination of cardenolide levels in animal tissues and plants as well as in the plasma (Schultz et al 2005).…”
Section: Distribution and Habitat-originally Introduced Frommentioning
confidence: 99%